Reuters logo
BRIEF-Ablynx gets first milestone in immuno-oncology deal with Merck & Co.
October 15, 2015 / 5:23 AM / 2 years ago

BRIEF-Ablynx gets first milestone in immuno-oncology deal with Merck & Co.

Oct 15 (Reuters) - Ablynx NV :

* Achieves first milestone in immuno-oncology collaboration with Merck & Co., Inc.

* To receive 3.5 million euros ($4.02 million) milestone payment Source text for Eikon: Further company coverage: ($1 = 0.8708 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below